Position in SPRB
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$2,802,870
-$1,771,564 QoQ
Shares Held
51,905
-25.8% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 63 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRB Over Time
Shares Held
Position Value (USD)
Derivatives in SPRB
reported options exposure · as of Sep 30, 2024CallValue
$1,045
CallShares
0
PutValue
$522
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. SPRB ranks #179 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in SPRB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,802,870 | 51,905 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $4,574,434 | 69,999 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,097,612 | 69,999 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $36,600 | 77,053 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $1,045 | 2,200 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $522 | 1,100 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $24,760 | 47,800 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $7,407 | 14,300 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $43,882 | 84,715 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,781 | 9,900 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $18,235 | 23,200 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $69,070 | 87,877 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $317,142 | 108,240 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $169,566 | 75,030 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $153,244 | 71,277 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,753,945 | 1,698,618 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,916,886 | 1,747,391 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,369,473 | 1,729,543 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,000,547 | 1,724,453 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,460,910 | 1,721,846 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,702,870 | 1,727,101 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,223,466 | 1,701,076 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,090,786 | 1,703,014 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $28,266,562 | 1,702,805 | Shares | Defined | 2021-05-21 | |
| 2020-12-31 | $41,370,441 | 1,701,787 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||